The 2017 BRICS Meeting on Drug Regulatory Collaboration held in Zhengzhou, China
The 2017 BRICS Meeting on Drug Regulatory Collaboration was held in Zhengzhou, China on July 13-14, 2017. Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), attended the meeting and delivered a speech, and the representatives of the relevant BRICS drug regulators and industries attended the meeting.
Since BRICS held their first drug regulation collaboration in 2015, all the member countries have attempted to establish normal cooperation mechanisms in drug evaluation and approval, drug supervision and check, pharmacovigilance, supply chain safety, etc. and they have made important contributions to ensuring the public health and safe medication of the peoples of all the member countries.
Source: the official website of China Food and Drug Administration